Partner | Jumpstart Nova
Kathryne Cooper, MBA is a native Angeleno passionate about growing and funding early-stage companies and creating a diverse ecosystem to support entrepreneurs.
As a Partner, Kathryne brings to Jumpstart Nova a history of operationalizing change and making astute early-stage investments in the healthcare arena. Kathryne prioritizes healthcare efficacy and business outcomes and knows how to integrate them into the investment landscape.
She founded HealthTechDEI to deliver more inclusive investment strategies and solutions that optimize financial performance and capitalize on the wealth in diversity, and authored the influential report Underinvested: Strategies for Supporting Diversity, Equity, and Inclusion in Health Care Venture Investment for the California Health Care Foundation. Kathryne is an Investment Advisor at The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) where from 2017-2021 she managed their $6.6M FDA-backed seed fund that invested in 150+ medical technology companies as Co-Director. Kathryne’s personal and professional journey as a Black female entrepreneur is featured in the award winning case study Kathryne Cooper and CTIP: Accelerating Diversity in Medtech, which illustrates how she transformed the accelerator’s portfolio.
Kathryne holds a BA in Human Biology from Stanford University, an MBA from the University of Southern California, Marshall School of Business and a Certificate in Venture Capital Finance from the University of California, Berkeley, School of Law. She began her career in medicine, attending medical school at the University of Southern California, Keck School of Medicine before transitioning to the business side of healthcare. She serves on the Board of Directors of the Bertran F. Cooper, M.D. Scholarship Fund via the Howard University College of Medicine and the Advisory Board of WiSTEM LA, a Women in Science, Technology, Engineering & Math [STEM] initiative, via the Office of the Los Angeles Mayor.
Kathryne nerds out connecting innovative people, products and ideas.
In light of changes to public policy, many companies have expressed support for advancing access to health care to individuals who are disproportionately affected by the changes. However, the emerging discrepancy between verbiage and action in investing in women’s reproductive health and other underrepresented communities is stark. This panel seeks to address the discrepancy in […]